BN Business News
Add your company to Business Communicator →

Prawo i regulacje · 05/04/2021

Royal Emerald Pharmaceuticals Seeks Registration as Controlled Substance Importer

Royal Emerald Pharmaceuticals Research and Development has submitted an application to the authorities to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Source: Federal Register — Justice DepartmentOpen original release →